Improvement within Clinical Trials
Genentech/Roche is enhancing the accessibility of clinical trials by providing comprehensive patient support services. By tackling common barriers to participation – such as travel costs, distance, parking, childcare, conflicting work schedules, health literacy, site location, capabilities, expectations, and privacy concerns – they aim to make clinical trials more inclusive and representative.
To Drive a Deeper Understanding of Cancer Disparities, American Cancer Society Launches Largest U.S. Population Study of Black Women
The American Cancer Society (ACS) has launched the VOICES of Black Women study, the largest population study in the United States focusing on behavioral and environmental factors affecting cancer risk and outcomes in Black women. This long-term study will enroll over 100,000 Black women across 20 states and Washington, D.C., encompassing areas where more than 90% of Black women reside. The study aims to understand cancer development, identify risk factors, and improve survivorship and outcomes post-diagnosis through meaningful community partnerships to capture participants’ lived experiences.
Social Determinants of Health and the Availability of Cancer Clinical Trials in the United States
The number of cancer clinical trials has significantly increased over the past decade, yet disparities in enrollment persist among minoritized and historically marginalized populations. Adverse social determinants of health (SDOH) and limited geographic availability of trials likely worsen this disparity. This study evaluated the association between county-level SDOH and cancer clinical trial availability in the United States, focusing on phase 2 and phase 3 interventional trials for the most common cancers from 2007 to 2022. Findings reveal that the most socially vulnerable counties were less likely to have any trial available, with availability worsening compared to the least socially vulnerable counties.
New Report from American Cancer Society Shows Mortality for Preventable Cancers Among Native Hawaiian and Other Pacific Islanders in U.S. is 2-3 times as High as White People
The American Cancer Society (ACS) has released a first-of-its-kind report, highlighting significant variations in cancer burden among Asian American, Native Hawaiian, and other Pacific Islander populations such as Chinese, Filipino, Korean, and Vietnamese individuals. The variations in cancer burden are attributed to a combination of factors, including immigration patterns, behavior, exposures in countries of origin, and social determinants of health. The report suggests tools to increase awareness and early detection in these communities and encourages lawmakers to support policies that enhance access to quality, culturally appropriate cancer care.
San Antonio Oncologists Tackle Rising Rates of Cancer Deaths in Latinos
Cancer is the leading cause of death for Latinos, accounting for 20% of all deaths. The University of Texas Health Science Center at San Antonio reported a projected 142% increase in cancer cases in the coming years. Despite advancements in cancer prevention, diagnosis, and treatment, disparities persist, with Latinos experiencing higher incidences of liver cancer and being twice as likely to die from cancer compared to other populations.
Upcoming Events:
- June 1st, 2024: Liver Life Walk NYC
- June 6th, 2024: “You’ve Got Cancer, Now What?”- Town Hall Discussion from John Theurer Cancer Center
- June 15th, 2024: Healthy Liver Day 2024 at The Ohio State
- September 13-16, 2024: GLI’s Advance Advocacy Academy (A3)
For more information about the Liver Cancers Council or to learn more about joining, please visit https://globalliver.org/liver-cancers-council/ or email cancer@globalliver.org